Company: JUNS
Filing Date: 2025-03-28
Form Type: 10-K
Source: 0001641172-25-001261
Chunk: 1356

Company: JUPITER NEUROSCIENCES, INC.
Filing Date: 2025-03-28
Form: 10-K
Item: Item 5
Chunk 1356
---
 table is c/o Jupiter Neurosciences, Inc., 1001 North
US Hwy 1, Suite 504, Jupiter, FL 33477. We have determined beneficial ownership in accordance with the rules of the SEC. We believe,
based on the information furnished to us, that the persons and entities named in the tables below have sole voting and investment power
with respect to all shares of common stock that they beneficially own, subject to applicable community property laws.

    Name and Address of Beneficial Owner 
    Amount and Nature of Shares Beneficial Ownership (1)
      
    Percentage of Class 
  
    Executive Officers and Directors: 

    Christer Rosén 
     12,571,758
    (2) 
     38.0%
  
    Marshall Hayward, Ph.D 
     3,625,382
    (3) 
     11.0 
  
    Saleem Elmasri 
     666,420
    (4) 
     2.0 
  
    Alison D. Silva 
     870,871
    (5) 
     2.6 
  
    Alexander Rosén 
     1,624,546
    (6) 
     4.9 
  
    Nicholas H. Hemmerly 
     193,737
    (7) 
     * 
  
    Julie Kampf 
     176,993
    (8) 
     * 
  
    Allison W. Brady 
     192,409
    (9) 
     * 
  
    Holger Weis 
     191,636
    (10) 
     * 
  
    All executive officers and directors as a group (9 persons) 
     20,113,752
    (11) 
     60.8%
  
    Other 5% Stockholders: 

    Claes Wahlestedt, M.D., Ph.D. 
     3,318,583
    (12) 
     10.0 
  
    Shaun Brothers 
     2,025,553
    (13) 
     6.1 

116

    *
    less
    than 1%.

    (1)
    The
    percentages in the table have been calculated based on 33,103,860 shares of our common stock outstanding on March 12, 2025. To
    calculate a stockholder’s percentage of